These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7369 related articles for article (PubMed ID: 2043590)

  • 21. Evaluation of recombinant human tumor necrosis factor by scheduled intratumoral administration in mice bearing transplantable tumors.
    Tamura K; Aso H; Nakamura T; Hemmi H; Ishida N
    Tohoku J Exp Med; 1989 Feb; 157(2):107-18. PubMed ID: 2711380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on anti-tumor activity of tumor necrosis factor alpha against human renal cell carcinoma cells heterotransplanted into nude mice].
    Shibayama T; Tachibana M; Tazaki H; Nakamura K
    Nihon Hinyokika Gakkai Zasshi; 1991 Oct; 82(10):1611-9. PubMed ID: 1770700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human TNF-alpha: preclinical studies and results from early clinical trials.
    Saks S; Rosenblum M
    Immunol Ser; 1992; 56():567-87. PubMed ID: 1550875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel recombinant tumor necrosis factor-alpha mutant with increased anti-tumor activity and lower toxicity.
    Nakamura S; Kato A; Masegi T; Fukuoka M; Kitai K; Ogawa H; Ichikawa Y; Maeda M; Watanabe N; Kohgo Y
    Int J Cancer; 1991 Jul; 48(5):744-8. PubMed ID: 1649139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Important role of serotonin in the antitumor effects of recombinant human tumor necrosis factor-alpha in mice.
    Manda T; Nishigaki F; Mori J; Shimomura K
    Cancer Res; 1988 Aug; 48(15):4250-5. PubMed ID: 3390820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions.
    Inagawa H; Nishizawa T; Honda T; Nakamoto T; Takagi K; Soma G
    Anticancer Res; 1998; 18(5D):3957-64. PubMed ID: 9854510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of the anti-tumor effect of actinomycin D by tumor necrosis factor alpha in mice: correlation between in vitro and in vivo results.
    Lasek W; Giermasz A; Kuc K; Wańkowicz A; Feleszko W; Gołab J; Zagozdzon R; Stokłosa T; Jakóbisiak M
    Int J Cancer; 1996 May; 66(3):374-9. PubMed ID: 8621260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of combined treatment with recombinant human tumor necrosis factor-alpha and 5-fluorouracil is dependent on the development of capillaries in tumor.
    Manda T; Nishigaki F; Mukumoto S; Masuda K; Nakamura T; Shimomura K
    Eur J Cancer; 1990 Feb; 26(2):93-9. PubMed ID: 2138912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral effects of recombinant human tumor necrosis factor-alpha in combination with natural interferon-beta in mice infected with herpes simplex virus type 1.
    Schmitt DA; Sasaki H; Pollard RB; Suzuki F
    Antiviral Res; 1992 Oct; 19(4):347-52. PubMed ID: 1463323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of recombinant IL-1 and recombinant tumor necrosis factor in the induction of mouse acute phase proteins.
    Mortensen RF; Shapiro J; Lin BF; Douches S; Neta R
    J Immunol; 1988 Apr; 140(7):2260-6. PubMed ID: 2450915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of intravesical administration of tumor necrosis factor alpha and systemic gamma-interferon on murine bladder cancer: lack of dose response.
    Lee K; O'Donnell RW; Cockett AT
    Urol Res; 1990; 18(4):287-9. PubMed ID: 2120837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel tumor-derived mediator that sensitizes cytokine-resistant tumors to tumor necrosis factor.
    Marvin MR; Libutti SK; Kayton M; Kao J; Hayward J; Grikscheit T; Fan Y; Brett J; Weinberg A; Nowygrod R; LoGerfo P; Feind C; Hansen KS; Schwartz M; Stern D; Chabot J
    J Surg Res; 1996 Jun; 63(1):248-55. PubMed ID: 8661206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).
    Curnis F; Sacchi A; Borgna L; Magni F; Gasparri A; Corti A
    Nat Biotechnol; 2000 Nov; 18(11):1185-90. PubMed ID: 11062439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compromised anti-tumor responses in tumor necrosis factor-alpha knockout mice.
    Baxevanis CN; Voutsas IF; Tsitsilonis OE; Tsiatas ML; Gritzapis AD; Papamichail M
    Eur J Immunol; 2000 Jul; 30(7):1957-66. PubMed ID: 10940885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic anhydride copolymer on solid tumors in mice.
    Kaneda Y; Yamamoto Y; Kamada H; Tsunoda S; Tsutsumi Y; Hirano T; Mayumi T
    Cancer Res; 1998 Jan; 58(2):290-5. PubMed ID: 9443407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor effect of recombinant human interleukin 1 alpha against murine syngeneic tumors.
    Nakamura S; Nakata K; Kashimoto S; Yoshida H; Yamada M
    Jpn J Cancer Res; 1986 Aug; 77(8):767-73. PubMed ID: 3093425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of tumor necrosis factor gene expression and protein synthesis in murine macrophages treated with recombinant tumor necrosis factor.
    Descoteaux A; Matlashewski G
    J Immunol; 1990 Aug; 145(3):846-53. PubMed ID: 2115544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor and interleukin-1 protection against the lethal effects of tumor necrosis factor.
    Sheppard BC; Norton JA
    Surgery; 1991 Jun; 109(6):698-705. PubMed ID: 2042087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local treatment of liver metastases with recombinant tumour necrosis factor (rTNF): a phase one study.
    IJzermans JN; van der Schelling GP; Scheringa M; Splinter TA; Marquet RL; Jeekel J
    Neth J Surg; 1991 Aug; 43(4):121-5. PubMed ID: 1944989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of subtumor regression dosage of TNF-alpha to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule.
    Lu Y; Yamauchi N; Koshita Y; Fujiwara H; Sato Y; Fujii S; Takahashi M; Sato T; Kato J; Yamagishi H; Niitsu Y
    Gene Ther; 2001 Apr; 8(7):499-507. PubMed ID: 11319616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 369.